Cytosorbents Corp (NASDAQ:CTSO) is held by 50 institutional investors per 13F filings through December 2025.
| Owner Name | Date | Shares Held | Change (QoQ) | Change (%) | Value (USD) |
|---|---|---|---|---|---|
| AVENIR CORP | 31 Dec, 2025 | 5,230,099 | 147,261 | 2.90% | $3,343,079.00 |
| AVENIR CORP | 31 Dec, 2025 | 5,215,776 | -14,323 | -0.27% | $2,953,694.00 |
| VANGUARD GROUP INC | 31 Dec, 2025 | 2,204,294 | 0 | 0.00% | $1,408,544.00 |
| VANGUARD CAPITAL MANAGEMENT LLC | 31 Dec, 2025 | 1,879,989 | 1,879,989 | 0.00% | $1,064,074.00 |
| Skylands Capital, LLC | 31 Dec, 2025 | 1,854,515 | -272,750 | -12.82% | $1,185,406.00 |
| Neuberger Berman Group LLC | 31 Dec, 2025 | 1,683,007 | 57,367 | 3.53% | $950,776.00 |
| Neuberger Berman Group LLC | 31 Dec, 2025 | 1,625,640 | 27,642 | 1.73% | $1,039,597.00 |
| CM Management, LLC | 31 Dec, 2025 | 1,476,500 | 188,372 | 14.62% | $943,779.00 |
| CM Management, LLC | 31 Dec, 2025 | 1,476,500 | 0 | 0.00% | $836,142.00 |
| BlackRock, Inc. | 31 Dec, 2025 | 782,992 | 12,441 | 1.61% | $443,408.00 |
| BlackRock, Inc. | 31 Dec, 2025 | 770,551 | 5,742 | 0.75% | $492,536.00 |
| GEODE CAPITAL MANAGEMENT, LLC | 31 Dec, 2025 | 707,262 | 103,495 | 17.14% | $400,621.00 |
| Sargent Investment Group, LLC | 31 Dec, 2025 | 612,000 | -126,700 | -17.15% | $391,190.00 |
| GEODE CAPITAL MANAGEMENT, LLC | 31 Dec, 2025 | 603,767 | 2,316 | 0.39% | $386,034.00 |
| Sargent Investment Group, LLC | 31 Dec, 2025 | 549,900 | -62,100 | -10.15% | $311,408.00 |
| Pathstone Holdings, LLC | 31 Dec, 2025 | 499,955 | 0 | 0.00% | $283,124.00 |
| Pathstone Holdings, LLC | 31 Dec, 2025 | 499,955 | 499,955 | 0.00% | $319,571.00 |
| VANGUARD FIDUCIARY TRUST CO | 31 Dec, 2025 | 313,856 | 313,856 | 0.00% | $177,642.00 |
| CIBC Private Wealth Group LLC | 31 Dec, 2025 | 172,649 | 0 | 0.00% | $110,357.00 |
| CIBC Bancorp USA Inc. | 31 Dec, 2025 | 172,649 | 172,649 | 0.00% | $97,771.00 |